Murine solid tumours as a novel model to study bacterial biofilm formation in vivo

Journal of Internal Medicine

Volumn 276, Issue 2, 2014, Pages 130-139

  Pawar, V ^a   Crull, K ^a   Komor, U ^a   Kasnitz, N ^a   Frahm, M ^a   Kocijancic, D ^a   Westphal, K ^a   Leschner, S ^a   Wolf, K ^a   Loessner, H ^a   Rohde, M ^a   Haussler S ^a   Weiss, S ^a  

^a INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

Author keywords

Biofilms; Mice; Pseudomonas aeruginosa; Salmonella typhimurium; Shigella flexneri; Solid tumours

Indexed keywords

ANTIBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; BIOFILM; CONTROLLED STUDY; DRUG EFFICACY; HOST; HOST PATHOGEN INTERACTION; IMMUNE SYSTEM; IN VIVO STUDY; MOUSE; MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; REVIEW; SALMONELLA; SALMONELLA TYPHIMURIUM; SOLID TUMOR; T LYMPHOCYTE;

BIOFILMS; MICE; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHIMURIUM; SHIGELLA FLEXNERI; SOLID TUMOURS;

ANIMALS; ANTIBIOSIS; BIOFILMS; HOST-PATHOGEN INTERACTIONS; MICE; NEOPLASMS, EXPERIMENTAL; NEUTROPHILS; PHAGOCYTOSIS; PSEUDOMONAS AERUGINOSA; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; T-LYMPHOCYTES;

EID: 84904258659     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12258     Document Type: Review

References (55)

1. Forbes NS. Engineering the perfect (bacterial) cancer therapy. Nat Rev Cancer 2010; 10: 785-94.
2. Leschner S, Weiss S. Salmonella-allies in the fight against cancer. J Mol Med (Berl) 2010; 88: 763-73.
3. Leschner S, Westphal K, Dietrich N et al. Tumor invasion of Salmonella enterica Serovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-α. PLoS ONE 2009; 4: e6692.
4. Thamm DH, Kurzman ID, King I et al. Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to Dogs with spontaneous neoplasia: phase I Evaluation. Clin Cancer Res 2005; 11: 4827-34.
5. Barbé S, Van Mellaert L, Anné J. The use of clostridial spores for cancer treatment. J Appl Microbiol 2006; 101: 571-8.
6. Pawelek JM, Low KB, Bermudes D. Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res 1997; 57: 4537-44.
7. Coley WB. The treatment of inoperable sarcoma with the mixed toxins of erysipelas and bacillus prodigiosus. J Am Med Assoc 1898; 20: 456-65.
8. Nauts H, McLaren J. Coley toxins-The first century. Consens Hyperth 1990; 267: 483-500.
9. Shelley MD, Kynaston H, Court J et al. A systematic review of intravesical bacillus Calmette-Guérin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer. BJU Int 2001; 88: 209-16.
10. Zhao M, Yang M, Li X-M et al. Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc Natl Acad Sci 2005; 102: 755-60.
11. Zhao M, Yang M, Ma H et al. Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice. Cancer Res 2006; 66: 7647-52.
12. Lee C-H, Wu C-L, Tai Y-S, Shiau A-L. Systemic administration of attenuated Salmonella choleraesuis in combination with cisplatin for cancer therapy. Mol Ther 2005; 11: 707-16.
13. Xu Y-F, Zhu L-P, Hu B et al. A new expression plasmid in Bifidobacterium longum as a delivery system of endostatin for cancer gene therapy. Cancer Gene Ther 2007; 14: 151-7.
14. Krick E, Sorenmo K. Evaluation of Clostridium novyi-NT spores in dogs with naturally occurring tumors. Am J Vet Res 2012; 73: 112-8.
15. Dang LH, Bettegowda C, Huso DL, Kinzler KW, Vogelstein B. Combination bacteriolytic therapy for the treatment of experimental tumors. Proc Natl Acad Sci 2001; 98: 15155-60.
16. Quispe-Tintaya W, Chandra D, Jahangir A et al. Nontoxic radioactive Listeria(at) is a highly effective therapy against metastatic pancreatic cancer. Proc Natl Acad Sci 2013; 110: 8668-73.
17. Saccheri F, Pozzi C, Avogadri F et al. Bacteria-induced gap junctions in tumors favor antigen cross-presentation and antitumor immunity. Sci Transl Med 2010; 2: 44-57.
18. Massa PE, Paniccia A, Monegal A, de Marco A, Rescigno M. Salmonella engineered to express CD20-targeting antibodies and a drug-converting enzyme can eradicate human lymphomas. Blood 2013; 122: 705-14.
19. Ledeboer NA, Frye JG, McClelland M, Jones BD. Salmonella enterica serovar Typhimurium requires the Lpf, Pef, and Tafi fimbriae for biofilm formation on HEp-2 tissue culture cells and chicken intestinal epithelium. Infect Immun 2006; 74: 3156-69.
20. Pawelek JM, Low KB, Bermudes D. Bacteria as tumour-targeting vectors. Lancet Oncol 2003; 4: 548-56.
21. Luo Y, Kong Q, Yang J et al. Complete genome sequence of the universal killer Salmonella enterica Serovar Typhimurium UK-1 (ATCC 68169). J Bacteriol 2011; 193: 4035-6.
22. Ruby T, McLaughlin L, Gopinath S, Monack D. Salmonella's long-term relationship with its host. FEMS Microbiol Rev 2012; 36: 600-15.
23. Crull K, Bumann D, Weiss S. Influence of infection route and virulence factors on colonization of solid tumors by Salmonella enterica serovar Typhimurium. FEMS Immunol Med Microbiol 2011; 62: 75-83.
24. Leschner S, Deyneko IV, Lienenklaus S et al. Identification of tumor-specific Salmonella Typhimurium promoters and their regulatory logic. Nucleic Acids Res 2012; 40: 2984-94.
25. Westphal K, Leschner S, Jablonska J, Loessner H, Weiss S. Containment of tumor-colonizing bacteria by host neutrophils. Cancer Res 2008; 68: 2952-60.
26. Römling U, Rohde M. Flagella modulate the multicellular behavior of Salmonella typhimurium on the community level. FEMS Microbiol Lett 1999; 180: 91-102.
27. Crull K, Rohde M, Westphal K et al. Biofilm formation by Salmonella enterica serovar Typhimurium colonizing solid tumours. Cell Microbiol 2011; 13: 1223-33.
28. Hoiseth S, Stocker B. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981; 291: 238-9.
29. Stocker BA. Aromatic-dependent Salmonella as anti-bacterial vaccines and as presenters of heterologous antigens or of DNA encoding them. J Biotechnol 2000; 83: 45-50.
30. Allen DB. Wound hypoxia and acidosis limit neutrophil bacterial killing mechanisms. Arch Surg 1997; 132: 991-6.
31. Walker TS, Tomlin KL, Worthen GS et al. Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils. Infect Immun 2005; 73: 3693-701.
32. Jesaitis AJ, Franklin MJ, Berglund D et al. Compromised host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions. J Immunol 2003; 171: 4329-39.
33. Gerstel U, Römling U. The csgD promoter, a control unit for biofilm formation in Salmonella typhimurium. Res Microbiol 2003; 154: 659-67.
34. Otto M. Bacterial sensing of antimicrobial peptides. Contrib Microbiol 2009; 16: 136-49.
35. Prost LR, Sanowar S, Miller SI. Salmonella sensing of anti-microbial mechanisms to promote survival within macrophages. Immunol Rev 2007; 219: 55-65.
36. Boddicker JD, Ledeboer NA, Jagnow J, Jones BD, Clegg S. Differential binding to and biofilm formation on, HEp-2 cells by Salmonella enterica serovar Typhimurium is dependent upon allelic variation in the fimH gene of the fim gene cluster. Mol Microbiol 2002; 45: 1255-65.
37. Monteiro C, Papenfort K, Hentrich K et al. Hfq and Hfq-dependent small RNAs are major contributors to multicellular development in Salmonella enterica serovar Typhimurium. RNA Biol 2012; 9: 489-502.
38. Cendra MDM, Juárez A, Torrents E. Biofilm modifies expression of ribonucleotide reductase genes in Escherichia coli. PLoS ONE 2012; 7: e46350.
39. Gómez MI, Prince A. Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis. Curr Opin Pharmacol 2007; 7: 244-51.
40. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318-22.
41. Rajan S, Saiman L. Pulmonary infections in patients with cystic fibrosis. Semin Respir Infect 2002; 17: 47-56.
42. Lyczak JB, Cannon CL, Pier GB. Lung Infections Associated with Cystic Fibrosis. Clin Microbiol Rev 2002; 15: 194-222.
43. Van Heeckeren AM, Schluchter MD. Murine models of chronic Pseudomonas aeruginosa lung infection. Lab Anim 2002; 36: 291-312.
44. Byrd MS, Pang B, Hong W et al. Direct evaluation of Pseudomonas aeruginosa biofilm mediators in a chronic infection model. Infect Immun 2011; 79: 3087-95.
45. Pelanda R, Braun U, Hobeika E, Nussenzweig MC, Reth M. B Cell progenitors are arrested in maturation but have intact VDJ recombination in the absence of Ig-α and Ig-β. J Immunol 2002; 169: 865-72.
46. Mulcahy H, Sibley CD, Surette MG, Lewenza S. Drosophila melanogaster as an animal model for the study of Pseudomonas aeruginosa biofilm infections in vivo. PLoS Pathog 2011; 7: e1002299.
47. Komor U, Bielecki P, Loessner H et al. Biofilm formation by Pseudomonas aeruginosa in solid murine tumors - a novel model system. Microbes Infect 2012; 14: 951-8.
48. Li X, Fu G-F, Fan Y-R et al. Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth. Cancer Gene Ther 2003; 10: 105-11.
49. Parker R, Plummber H, Siebenmann C, Chapman G. Effect of histolyticus infection and toxin on transplantable mouse tumors. Proc Soc Exp Biol Med 1947; 66: 461-5.
50. Möse J, Möse G. Oncolysis by clostridia. I. Activity of Clostridium butyricum(M-55) and other nonpathogenic clostridia against the Ehrlich carcinoma. Cancer Res 1964; 24: 212-6.
51. Lemmon M, Van Z, Fox M et al. Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment. Gene Ther 1997; 8: 791-6.
52. Weibel S, Stritzker J, Eck M, Goebel W, Szalay A. Colonization of experimental murine breast tumours by Escherichia coli K-12 significantly alters the tumour microenvironment. Cell Microbiol 2008; 10: 1235-48.
53. Zhang Y, Zhang Y, Xia L et al. Escherichia coli Nissle 1917 targets and restrains mouse B16 melanoma and 4T1 breast tumors through expression of azurin protein. Appl Environ Microbiol 2012; 78: 7603-10.
54. Momiyama M, Zhao M, Kimura H et al. Inhibition and eradication of human glioma with tumor-targeting Salmonella typhimurium in an orthotopic nude-mouse model. Cell Cycle 2012; 11: 628-32.
55. Bielecki P, Komor U, Bielecka A et al. Ex vivo transcriptional profiling reveals a common set of genes important for the adaptation of Pseudomonas aeruginosa to chronically infected host sites. Environ Microbiol 2013; 15: 570-7.